Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

Marathon Pharma to Pause Muscular Dystrophy Drug Launch After Criticism of 6,000% Price Hike
Marathon Pharma to Pause Muscular Dystrophy Drug Launch After Criticism of 6,000% Price Hike
Another drug company reignited the debate over appropriate pricing policies for important medications.
Tom Price confirmed as HHS Secretary
Tom Price confirmed as HHS Secretary
WASHINGTON — Rep.
Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer’s Disease to Stop for Lack of Efficacy
Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer’s Disease to Stop for Lack of Efficacy
KENILWORTH, N.
Children may inherit drug protection from fathers' nicotine use
Children may inherit drug protection from fathers' nicotine use
Feb.
Anti-ageing hormone 'Klotho' could prevent kidney disease in diabetics
Anti-ageing hormone 'Klotho' could prevent kidney disease in diabetics
London.
Immunomedics out-licenses cancer drug candidate for up to $2 billion
Immunomedics out-licenses cancer drug candidate for up to $2 billion
The USA’s Immunomedics (Nasdaq.
Drugmaker Ipsen to buy some products from Sanofi for 83 million euros
Drugmaker Ipsen to buy some products from Sanofi for 83 million euros
Drugmaker Ipsen (IPN.
Aspirin, more than painkiller, can help prevent cancer: study
Aspirin, more than painkiller, can help prevent cancer: study
WASHINGTON, Feb.
Aurobindo Pharma to open second U.S. plant
Aurobindo Pharma to open second U.S. plant
HYDERABAD, India — Aurobindo Pharma said on Friday it plans to open a second U.
FDA approves Emflaza for Duchenne muscular dystrophy
FDA approves Emflaza for Duchenne muscular dystrophy
NORTHBROOK, Ill.
Academics call time on $100,000 cancer drugs
Academics call time on $100,000 cancer drugs
A group of academic researchers has demanded an end to cancer medicines costing more than $100,000 a year and proposed a new model of low-cost drug development that would capitalize on recent advances...
Studies of Potential Alzheimer’s Disease Treatment Developed by ChemDiv and Avineuro Published in Two Peer-reviewed Scientific Journals
Studies of Potential Alzheimer’s Disease Treatment Developed by ChemDiv and Avineuro Published in Two Peer-reviewed Scientific Journals
SAN DIEGO, CA, February 16, 2017 – As 2016 was coming to a close, two leading fundamental research journals, Molecular Pharmaceutics and Current Alzheimer Research, independently published studies o...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand